SANOFI CONS HEALTHC IND L (SANOFICONR) - Total Liabilities
Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has total liabilities worth Rs1.63 Billion INR (≈ $17.63 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of SANOFI CONS HEALTHC IND L to evaluate the company's liquid asset resilience ratio.
SANOFI CONS HEALTHC IND L - Total Liabilities Trend (2023–2025)
This chart illustrates how SANOFI CONS HEALTHC IND L's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SANOFICONR total assets.
SANOFI CONS HEALTHC IND L Competitors by Total Liabilities
The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alumis Inc
NASDAQ:ALMS
|
USA | $108.46 Million |
|
Sam Hwa Capaci
KO:001820
|
Korea | ₩58.96 Billion |
|
Jiangsu Yinhe Electronics Co Ltd
SHE:002519
|
China | CN¥1.04 Billion |
|
Yangmei Chemical Co Ltd
SHG:600691
|
China | CN¥11.32 Billion |
|
Magellan Financial Group Ltd
AU:MFG
|
Australia | AU$90.50 Million |
|
Ventyx Biosciences Inc
NASDAQ:VTYX
|
USA | $20.10 Million |
|
Luoniushan Co Ltd
SHE:000735
|
China | CN¥4.97 Billion |
|
CSSC Offshore & Marine Engineering (Group) Co Ltd
F:GSZ
|
Germany | €33.91 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down SANOFI CONS HEALTHC IND L's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SANOFICONR net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SANOFI CONS HEALTHC IND L's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual total liabilities of SANOFI CONS HEALTHC IND L from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rs1.63 Billion ≈ $17.63 Million |
+2.97% |
| 2024-12-31 | Rs1.58 Billion ≈ $17.12 Million |
+14.88% |
| 2023-12-31 | Rs1.38 Billion ≈ $14.90 Million |
-- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more